The Pharmaceutical Journal
Vol 274 No 7334 p102
29 January 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Industry gives evidence

The Health Committee inquiry into the influence of the pharmaceutical industry heard from the industry itself last week. The industry claimed that focusing on patients was the way to achieve a balance between commercial imperatives and public health concerns. Other topics covered included accusations of the industry inventing diseases, direct-to-consumer advertising and “evergreening” (extending the life of a product beyond patent expiry).